143 - Jason Kelly, PhD, CEO & Co-founder of Ginkgo Bioworks, the $15 Billion Synthetic Biology Company That’s Starting the Next Industrial Revolution

Today we are doing a deep dive into the revolutionary new field of synthetic biology.  I’m thrilled to be joined by Dr. Jason Kelly, the CEO and co-founder of the company that’s leading this revolution, Ginkgo Bioworks.

Ginkgo is the largest designer of synthetic DNA in the world, and programs cells for customers in the chemical, pharmaceutical, food, and energy industries. It’s valued at $15 billion and has been listed for the past three years on CNBC's Disruptor 50 List of fast-growing companies.

I truly believe this field will dramatically transform future industries in the way that Apple and Microsoft have changed our lives with technology – and Jason tells the story of how this future is possible on today’s show.